Mesothelioma Victims Encouraged as Judge Rejects J&J Bankruptcy Again

Tens of thousands of mesothelioma and ovarian victims have been watching and waiting as a New Jersey bankruptcy judge considered a second bankruptcy filing from consumer giant Johnson & Johnson. The victims, who blame the company for negligently exposing them to asbestos-contaminated talc in their iconic baby powder product, learned late last summer that the court had again rejected the company’s claim, noting that they continued to demonstrate that their economic situation justified having their financial liabilities discharged.

Johnson & Johnson

New Jersey Bankruptcy Judge’s Decision Inspires Hope that Mesothelioma Victims Will See Justice

Like several other companies facing significant mesothelioma claims, Johnson & Johnson elected to pursue a controversial legal maneuver known as a Texas two-step in which they established a new subsidiary, LTL Management that held all of their asbestos liabilities, then filed for bankruptcy protection. The maneuver effectively put all outstanding claims on hold, leaving sick and dying victims waiting for the courts to address the issue.

U.S. Bankruptcy Judge Michael Kaplan had initially approved the petition, only to have his decision overturned by the U.S. appeals court, which noted that bankruptcy protection was inappropriate for companies that were not facing significant financial distress. The company then attempted the maneuver again, submitting new arguments in support of its claim and offering an $8.9 billion settlement for victims. Judge Kaplan’s recent denial of this second application is offering mesothelioma victims new hope.

Disagreement Among Mesothelioma Victims

The group that is trying to block the bankruptcy petition is made up of people diagnosed with malignant mesothelioma or ovarian cancer, or their survivors. Some others who have suffered the same fate and who have outstanding claims against Johnson & Johnson are in favor of accepting the settlement, but the plaintiffs argue that the company’s offer does not provide enough for victims who have not submitted claims because they have not yet been diagnosed with an asbestos-related disease.

Johnson & Johnson continues to argue that their product is safe and never contained asbestos, but one of the plaintiffs’ attorneys responded by saying, “J&J has spent two years trying to convince us that somehow a company worth a half-trillion dollars is bankrupt. It’s time for the nonsense to stop and for J&J to accept responsibility.”

Abogado especializado en mesotelioma analiza opciones de compensación con Meso-Book

Paquete de compensación financiera GRATUITO

  • Información sobre despachos de abogados que recuperarán su INDEMNIZACIÓN MÁS ALTA
  • Aprenda cómo cobrar en 90 días
  • Solicite su parte de $30 mil millones en fondos fiduciarios
Pablo Danziger

Pablo Danziger

Revisor y editor

Paul Danziger creció en Houston, Texas, y se licenció en Derecho en la Facultad de Derecho de la Universidad Northwestern en Chicago. Durante más de 25 años, se ha dedicado a representar a víctimas de mesotelioma y a otras personas afectadas por la exposición al asbesto. Paul y su bufete han representado a miles de personas diagnosticadas con mesotelioma, asbestosis y cáncer de pulmón, obteniendo indemnizaciones significativas para los clientes lesionados. Cada cliente es fundamental para Paul y atenderá todas las llamadas de quienes deseen hablar con él. Paul y su bufete se encargan de casos de mesotelioma en todo Estados Unidos.

Conéctese con el abogado especializado en mesotelioma Paul Danziger